By Greg Collier In recent years, DNA testing has become mainstream, with companies like 23andMe offering consumers a window into their ancestry, health risks, and […]
Category: Healthcare
Ozempic and the Global Drug Pricing Debate
By Greg Collier As Novo Nordisk continues to dominate the pharmaceutical industry with its diabetes and obesity drugs, Ozempic and Wegovy, the company faces mounting […]